Ariella Heffernan-Marks’ Ovum Award Turns Trust Into the Main Metric

Dr Ariella Heffernan-Marks has been named Best New Founder at the Startup Daily Best in Tech Awards, giving Ovum another public marker in a year when the women’s health AI company has moved from early traction to a more serious infrastructure question.

The headline numbers are strong. Ovum has passed 20,000 downloads, facilitated more than 113,000 AI health conversations and built partnerships across organisations including Medibank, Fernwood Fitness and iScreen. It also raised a seed round earlier this year, giving the company the kind of financial runway that many women’s health startups struggle to secure.

But the more important number may be less obvious: 83 percent of users have opted in to contribute anonymised health information. That matters because women’s health AI cannot be judged only by downloads or pitch-deck language. It depends on whether women trust the product enough to record sensitive patterns, bring that information into healthcare conversations and, where they choose, contribute to a dataset designed to address long-running gaps in women’s health research.

Ovum’s product brings symptoms, wearable data, test results, medications, lifestyle information and medical history into one AI-powered journal. The practical promise is that women can spot patterns over time and walk into appointments better prepared. The bigger promise is that a longitudinal women’s health dataset could help researchers and clinicians understand conditions, treatments and life-stage changes with more nuance than fragmented records allow.

That makes the award more than founder recognition. It surfaces the kind of company-building challenge women’s health technology now faces. A founder in this space has to build a product that is usable, clinically responsible, privacy-conscious and commercially durable, while also working around a healthcare system where many women have already learned to expect delay, dismissal or partial answers.

Heffernan-Marks’ own background as a doctor and patient gives the company a clear founder-market fit, but founder story alone is not enough. Women’s health is full of products that use empowerment language without changing the underlying experience. The test for Ovum is whether its summaries, pattern recognition and data model genuinely help women have better medical conversations and whether clinicians, researchers and partners treat the resulting information with care.

For SheMeansNews readers, the useful angle is trust as a business asset. In AI, trust is often discussed as reputation management. In women’s health, it is operational. If users do not believe the company understands their context, protects their information and builds for real clinical moments, the dataset does not grow and the product loses its reason to exist.

That is why Heffernan-Marks’ award is a founder story, but also a category story. Women’s health AI is moving beyond the idea stage. The companies that matter will be the ones that can turn sensitive, consent-based data into better care without treating women’s stories as raw material for hype.